The fact that some patients had primary tumor surgery more then 6 months before treatment start (Table 1) also did not have any significant impact on the observed changes on CEC, CEP, KIT+ CD11b+ cells and M2 markers (data not show). This evidence concerns the gene ITGAM and neoplasm.